Revenue
45.3 million USD
2025 Q3 · USD
Exact inputs and evidence
- Revenue: 45300000 USD Source
Market value is not computed: no recent price is available.
Annual consolidated revenue for 2024: about USD 19.6M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2023, was about USD 14.9M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
This issuer has insider filings in the store, but no transaction in this window or code group.
45.3 million USD
2025 Q3 · USD
96.72%
2025 Q3 · %
1.91 million USD
2025 Q3 · USD
1.91 million USD
2025 Q3 · USD
2777000 USD
41788096 shares
0.09% · 38 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
52.6 million USD
2024-10-01 – 2025-09-30
8.04 million USD
2024-10-01 – 2025-09-30
-22.4 million USD
2024-10-01 – 2025-09-30
0 USD
2024-10-01 – 2025-09-30
-22.4 million USD
2024-10-01 – 2025-09-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2025-11-12.
Financial data available through: 2024-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 14.9 million
–
Current period
USD 19.6 million
–
19600000 − 14900000 = 4700000 USD
14900000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source19600000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 86.88 million
–
Current period
−USD 60.48 million
–
-60477000 − -86879000 = 26402000 USD
-86879000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-60477000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 81.18 million
–
Current period
−USD 59.92 million
–
-59917000 − -81177000 = 21260000 USD
-81177000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-59917000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 1.13 million
–
Current period
USD 123,000
–
123000 − 1132000 = -1009000 USD
1132000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source123000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | 990000 | 36186000 Derived | -35196000 | -1744000 Derived | -33452000 | -34816000 Derived | Source
|
| 2016 2016-01-01 – 2016-12-31 | 29981000 | 27115000 Derived | 2866000 | 975000 Derived | 1891000 | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 425000 | 29680000 Derived | -29255000 | -226000 Derived | -29029000 | -17810000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 9800000 | 65962000 Derived | -56162000 | 5064000 Derived | -61226000 | -9776000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 14900000 | 103631000 Derived | -88731000 | -1852000 Derived | -86879000 | -82309000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 19600000 | 81779000 Derived | -62179000 | -1702000 Derived | -60477000 | -60040000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Revenue | 2243000 |
|
| 2015 | Revenue | 990000 |
|
| 2016 | Revenue | 29981000 |
|
| 2017 | Revenue | 425000 |
|
| 2022 | Revenue | 9800000 |
|
| 2023 | Revenue | 14900000 |
|
| 2024 | Revenue | 19600000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Year over year | No prior comparable period |
|
| 2015 | Year over year | -55.9% |
|
| 2016 | Year over year | 2,928.4% |
|
| 2017 | Year over year | -98.6% |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | 52% |
|
| 2024 | Year over year | 31.5% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Operating margin | -1,468.2% |
|
| 2015 | Operating margin | -3,555.2% |
|
| 2016 | Operating margin | 9.6% |
|
| 2017 | Operating margin | -6,883.5% |
|
| 2022 | Operating margin | -573.1% |
|
| 2023 | Operating margin | -595.5% |
|
| 2024 | Operating margin | -317.2% |
|
| 2014 | Net margin | -1,522.8% |
|
| 2015 | Net margin | -3,379% |
|
| 2016 | Net margin | 6.3% |
|
| 2017 | Net margin | -6,830.4% |
|
| 2022 | Net margin | -624.8% |
|
| 2023 | Net margin | -583.1% |
|
| 2024 | Net margin | -308.6% |
|
| 2014 | Free cash flow margin | Not reported |
|
| 2015 | Free cash flow margin | -3,516.8% |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | -4,190.6% |
|
| 2022 | Free cash flow margin | -99.8% |
|
| 2023 | Free cash flow margin | -552.4% |
|
| 2024 | Free cash flow margin | -306.3% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Operating cash flow | Not reported | No source recorded |
| 2015 | Operating cash flow | -34529000 |
|
| 2016 | Operating cash flow | 2538000 |
|
| 2017 | Operating cash flow | -17800000 |
|
| 2022 | Operating cash flow | -5116000 |
|
| 2023 | Operating cash flow | -81177000 |
|
| 2024 | Operating cash flow | -59917000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Free cash flow | Unavailable | No source recorded |
| 2015 | Free cash flow | -34816000 |
|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | -17810000 |
|
| 2022 | Free cash flow | -9776000 |
|
| 2023 | Free cash flow | -82309000 |
|
| 2024 | Free cash flow | -60040000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014-12-31 | Liabilities / assets | Not reported |
|
| 2015-12-31 | Liabilities / assets | Not reported |
|
| 2016-12-31 | Liabilities / assets | Not reported |
|
| 2017-12-31 | Liabilities / assets | Not reported |
|
| 2022 | Liabilities / assets | 148.3% |
|
| 2023 | Liabilities / assets | 70.4% |
|
| 2024 | Liabilities / assets | 191.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Current assets / current liabilities | 10.46× |
|
| 2015 | Current assets / current liabilities | 4.79× |
|
| 2016 | Current assets / current liabilities | 6.51× |
|
| 2017 | Current assets / current liabilities | 3.17× |
|
| 2022 | Current assets / current liabilities | 2.78× |
|
| 2023 | Current assets / current liabilities | 5.06× |
|
| 2024 | Current assets / current liabilities | 1.48× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | −USD 33.45 million Exact valueExact value: -33452000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 34.53 million Exact valueExact value: -34529000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 287,000 Exact valueExact value: 287000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 34.82 million Calculation and evidence-34529000 − 287000 USD Exact free cash flow: -34816000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2016 2016-01-01 – 2016-12-31 | USD 1.89 million Exact valueExact value: 1891000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.54 million Exact valueExact value: 2538000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | −USD 29.03 million Exact valueExact value: -29029000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.8 million Exact valueExact value: -17800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 10,000 Exact valueExact value: 10000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 17.81 million Calculation and evidence-17800000 − 10000 USD Exact free cash flow: -17810000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 33.69 million Exact valueExact value: -33693000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22.8 million Exact valueExact value: -22800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2,000 Exact valueExact value: 2000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22.8 million Calculation and evidence-22800000 − 2000 USD Exact free cash flow: -22802000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 107.5 million Exact valueExact value: -107500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 37.5 million Exact valueExact value: -37500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 136,000 Exact valueExact value: 136000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 37.64 million Calculation and evidence-37500000 − 136000 USD Exact free cash flow: -37636000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 22.4 million Exact valueExact value: -22397000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 30.8 million Exact valueExact value: -30800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8,000 Exact valueExact value: 8000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 30.81 million Calculation and evidence-30800000 − 8000 USD Exact free cash flow: -30808000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 336,000 Exact valueExact value: -336000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 68.9 million Exact valueExact value: -68900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4,000 Exact valueExact value: 4000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 68.9 million Calculation and evidence-68900000 − 4000 USD Exact free cash flow: -68904000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 61.23 million Exact valueExact value: -61226000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.12 million Exact valueExact value: -5116000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4.66 million Exact valueExact value: 4660000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.78 million Calculation and evidence-5116000 − 4660000 USD Exact free cash flow: -9776000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 86.88 million Exact valueExact value: -86879000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 81.18 million Exact valueExact value: -81177000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.13 million Exact valueExact value: 1132000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 82.31 million Calculation and evidence-81177000 − 1132000 USD Exact free cash flow: -82309000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 60.48 million Exact valueExact value: -60477000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 59.92 million Exact valueExact value: -59917000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 123,000 Exact valueExact value: 123000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 60.04 million Calculation and evidence-59917000 − 123000 USD Exact free cash flow: -60040000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
139 filings · 3,014 latest values · 3,005 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001485003, 1485003, CARM, EBIO, SESN, edgar:1485003
Also known as CARISMA THERAPEUTICS INC., Carisma Therapeutics Inc., Carisma Therapeutics Inc., Eleven Biotherapeutics, Inc., SESEN BIO, INC., SESEN BIO, INC., Sesen Bio, Inc.